APVMA VETERINARY USE PERMIT 13713- XYLAZINE/ CATTLE/ SEDATION PRIOR TO EUTHANASIA

País: Austrália

Língua: inglês

Origem: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredientes ativos:

xylazine(100mg/mL)

Disponível em:

APVMA PERMIT

DCI (Denominação Comum Internacional):

xylazine(100mg/mL)

Fabricado por:

QLD DAF

Área terapêutica:

analgesic,sedative

Resumo do produto:

For sedation of animals prior to euthanasia.

Status de autorização:

Registered and available

Data de autorização:

2012-09-04

Folheto informativo - Bula

Permit PER13713
Permit Version 2
Page 1 of 2 PERMIT TO ALLOW THE MINOR OFF-LABEL USE OF A REGISTERED
VETERINARY CHEMICAL PRODUCT
PERMIT NUMBER –PER13713
This permit is issued to the Permit Holder in response to an
application granted by the
APVMA under section 112 of the Agvet Codes of the jurisdictions set
out below. This permit
allows a person, as stipulated below, to use the product in the manner
specified in this permit in
the designated jurisdictions. This permit also allows any person to
claim that the product can
be used in the manner specified in this permit.
If this permit were not issued, supply and use of
the product, as specified below, would constitute an offence under
section 79 of the Agvet Code.
THIS PERMIT IS IN FORCE FROM 04 SEPTEMBER 2012 TO 31 DECEMBER 2017.
PERMIT HOLDER:
BIOSECURITY QUEENSLAND
Department of Agiculture, Fisheries and Forestry,
Level 5, Primary Industries Building,
80 Ann Street
BRISBANE QLD 4001
PERSONS WHO CAN USE THE PRODUCTS UNDER THIS PERMIT:
Registered veterinary surgeons, officers of Biosecurity Queensland and
any other person, acting
under the direct supervision of a registered veterinary surgeon.
DOSE AND ADMINISTRATION:
As directed by a registered veterinary surgeon.
CONDITIONS OF USE
PRODUCTS TO BE USED:
Any veterinary chemical product containing 100 mg/mL XYLAZINE as their
only active
constituent and is registered for use in horses and/or cattle.
CRITICAL USE COMMENTS:
1.
This Permit comes into force after notification of an emergency
disease by the
State/Territory Chief Veterinary Officer(s) to the Consultative
Committee on Exotic Animal
Diseases (CCEAD) and following invocation of the CCEAD Response
Agreement under
Permit PER13713
Permit Version 2
Page 2 of 2
AUSVETPLAN; or, following the declaration of an emergency disease
incident by the
Queensland Chief Veterinary Officer using powers provided in the
legislation of that State
or Territory.
2.
The use of any veterinary chemical product containing 100mg/mL
xylazine that is
registered for sedation of animals pr